Branchburg, NJ, United States of America

Richard D Scheyer

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard D Scheyer. Retrieved from https://idiyas.com/inventor/richard-d-scheyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard D. Scheyer: Innovator in Pharmaceutical Treatments

Introduction

Richard D. Scheyer is a notable inventor based in Branchburg Township, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of behavioral and psychological symptoms associated with various diseases.

Latest Patents

Richard D. Scheyer holds a patent for the use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug. This invention is directed towards treating patients for behavioral or psychological symptoms associated with Alzheimer's disease, Lewy body dementia, or Parkinson's disease. His innovative approach aims to improve the quality of life for individuals suffering from these conditions.

Career Highlights

Scheyer is associated with Aventis Pharmaceuticals Inc., where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating effective treatments that address complex neurological symptoms.

Collaborations

Some of his notable coworkers include Stephen M. Sorensen and Janice M. Hitchcock. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical industry.

Conclusion

Richard D. Scheyer's contributions to pharmaceutical innovations highlight his commitment to improving patient care through effective treatments. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…